Claire brings a dual background as an operating executive and an investor in medtech. At SafeHeal, a company created by the MD Start accelerator, she served as COO and then VP Clinical Affairs, where she led the regulatory and clinical pathways from prototype through CE mark to the pivotal US IDE trial. She grew the team from 1 to 15 and contributed to fundraising rounds through Series B. She was previously Program Manager at MD Start, following earlier roles in clinical affairs, regulatory and product at Theraclion and Mauna Kea. She is also a Partner at 50 Partners Health and HTX Index. At M2care, she leads dealflow and the hands-on support of portfolio companies. Claire is a graduate of ENSTA ParisTech and holds a Master’s degree in Biomedical Engineering from Université Paris Descartes.
